Crossject S.A (ALCJ) | Financial Analysis & Statements
Crossject S.A. | Small-cap | Healthcare
Crossject S.A. | Small-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
0
Gross Profit
-9.2M
Operating Income
-13.0M
Net Income
-12.8M
Balance Sheet Metrics
Total Assets
31.6M
Total Liabilities
34.2M
Shareholders Equity
-2.7M
Cash Flow Metrics
Operating Cash Flow
-13.1M
Free Cash Flow
-11.5M
Revenue & Profitability Trend
Crossject S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 145.0K | 954.0K | 912.0K | 0 |
| Cost of Goods Sold | 9.2M | 6.3M | 2.2M | 1.3M | 563.0K |
| Gross Profit | -9.2M | -6.1M | -1.2M | -390.0K | -563.0K |
| Operating Expenses | 569.0K | -188.0K | 1.3M | 969.0K | 956.0K |
| Operating Income | -13.0M | -11.8M | -13.3M | -11.8M | -10.6M |
| Pre-tax Income | -15.6M | -11.5M | -13.4M | -12.6M | -11.5M |
| Income Tax | -2.8M | -2.9M | -2.2M | -1.8M | -1.6M |
| Net Income | -12.8M | -8.6M | -11.2M | -10.8M | -9.8M |
| EPS (Diluted) | - | -€0.23 | -€0.30 | -€0.41 | -€0.40 |
Income Statement Trend
Crossject S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 15.9M | 10.7M | 13.8M | 14.4M | 18.7M |
| Non-Current Assets | 15.7M | 18.0M | 19.0M | 17.1M | 14.9M |
| Total Assets | 31.6M | 28.6M | 32.9M | 31.5M | 33.6M |
| Liabilities | |||||
| Current Liabilities | 6.9M | 6.5M | 5.3M | 3.1M | 3.6M |
| Non-Current Liabilities | 27.4M | 27.4M | 24.8M | 33.9M | 31.1M |
| Total Liabilities | 34.2M | 33.9M | 30.2M | 37.0M | 34.7M |
| Equity | |||||
| Total Shareholders Equity | -2.7M | -5.3M | 2.7M | -5.5M | -1.1M |
Balance Sheet Composition
Crossject S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -12.8M | -8.6M | -11.2M | -10.8M | -9.8M |
| Operating Cash Flow | -13.1M | -8.7M | -11.2M | -10.8M | -9.9M |
| Investing Activities | |||||
| Capital Expenditures | -3.4M | -2.6M | -6.8M | -6.7M | -6.1M |
| Investing Cash Flow | -3.4M | -2.6M | -6.8M | -6.7M | -6.1M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 16.1M | 3.4M | 9.6M | 14.5M | 11.9M |
| Free Cash Flow | -11.5M | -12.6M | -11.9M | -12.8M | -11.6M |
Cash Flow Trend
Crossject S.A Key Financial Ratios
Valuation Ratios
Forward P/E
7.40
Price to Sales
19.57
PEG Ratio
7.40
Profitability Ratios
Profit Margin
0.00%
Operating Margin
-246.47%
Return on Equity
478.68%
Return on Assets
-26.91%
Financial Health
Current Ratio
1.66
Debt to Equity
-7.88
Beta
0.90
Per Share Data
EPS (TTM)
-€0.28
Book Value per Share
-€0.06
Revenue per Share
€0.09
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| alcj | 80.5M | - | - | 478.68% | 0.00% | -7.88 |
| Amplitude Surgical | 295.0M | 307.50 | 3.12 | 1.15% | 1.00% | 126.32 |
| Visiomed Group SA | 53.2M | 57.80 | 2.10 | 3.68% | 6.58% | 32.03 |
| Bonyf N.V | 8.2M | - | 18.85 | -38.97% | 8.54% | 0.00 |
| Spineway S.A | 3.9M | 0.02 | 0.07 | -17.85% | -30.35% | 7.50 |
| I.Ceram S.A | 155.7K | 9.88 | 0.46 | -124.00% | -170.02% | 476.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.